← Back

Zhejiang Shouxiangu Pharm Co

Zhejiang Shouxiangu Pharmaceutical Co., Ltd., along with its subsidiaries, breeds, cultivates, processes, and sells Chinese medicinal herbs in China and internationally. Under the Shouxiangu brand, it offers ganoderma lucidum spore powder, dendrobium officinale, and saffron products, as well as health and ordinary food, agricultural and sideline products, personal and skincare items, and traditional Chinese medicines. The company also engages in wholesale and retail, technology research and development, and real estate. Founded in 1909, it is headquartered in Jinhua, China.

Country
Price · split & dividend adjusted
News & notes moving 603896.CG
603896.CG2

Shouxiangu's 2026 interim report shows net profit down 43.76%

Shouxiangu released its 2026 interim report. Total operating revenue was 276 million yuan, down 7.89% year on year. Net profit attributable to the parent company was 36.8708 million yuan, down 43.76% from the same period last year. Net cash flow from operating activities was negative 35.2611 million yuan, down 128.67% year on year. Gross margin was 76.79%, down 4.02 percentage points from a year earlier. Return on equity was 1.61%, down 1.22 percentage points. Diluted earnings per share were 0.19 yuan, down 42.42% year on year.
Jiemian·24dRead more →